Annals of the New York Academy of Sciences

Number of times cited: 37

• Udaya S Tantry, Elisabeth Mahla, Martin G Gesheff and Paul A Gurbel, Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account, Expert Review of Cardiovascular Therapy, 11, 11, (1547), (2013).
  Crossref
• Marian A. Packham and Margaret L. Rand, Historical perspective on ADP-induced platelet activation, Purinergic Signalling, 7, 3, (283), (2011).
  Crossref
• D. C. B. Mills, Initial Biochemical Responses of Platelets to Stimulation, Ciba Foundation Symposium 35 ‐ Biochemistry and Pharmacology of Platelets, (153-173), (2008).
  Wiley Online Library
• W. Schneider and A. R. L. Gear, Significance of Glucose and Glycogen Metabolism for Platelet Function, Ciba Foundation Symposium 35 ‐ Biochemistry and Pharmacology of Platelets, (225-238), (2008).
  Wiley Online Library
• Jean‐Etienne Fabre, Brian F. King and Beverly H. Koller, Study of aggregation of platelets lacking the P2Y1 receptor, Drug Development Research, 52, 1‐2, (150-155), (2001).
  Wiley Online Library
• Patricia Clutton, John D. Folts and Jane E. Freedman, Pharmacological control of platelet function, Pharmacological Research, 44, 4, (255), (2001).
  Crossref
• Noel J Cusack and Susanna M.O Hourani, Platelet P2 receptors: from curiosity to clinical targets, Journal of the Autonomic Nervous System, 81, 1-3, (37), (2000).
  Crossref
• Robert F. Storey, Heather M. Sanderson, Ann E. White, Jane A. May, Kathryn E. Cameron and Stan Heptinstall, The central role of the P receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity, British Journal of Haematology, 110, 4, (925-934), (2001).
  Wiley Online Library
• James L. Daniel, Carol Dangelmaier, Jianguo Jin, Barrie Ashby, J. Bryan Smith and Satya P. Kunapuli, Molecular Basis for ADP-induced Platelet Activation, Journal of Biological Chemistry, 273, 4, (2024), (1998).
  Crossref
• Rajinder N. Puri and Robert W. Colman, Immunoaffinity Method to Identify Aggregin, a Putative ADP–Receptor in Human Blood Platelets, Archives of Biochemistry and Biophysics, 347, 2, (263), (1997).
  Crossref
• Rajinder N. Puri and Robert W. Colman, Inhibition of ADP‐induced platelet activation by 7‐chloro‐4‐nitrobenz‐2‐oxa‐1,3‐diazole: Covalent modification of aggregin, a putative ADP receptor, Journal of Cellular Biochemistry, 61, 1, (97-108), (1998).
  Wiley Online Library
• Rajinder N. Puri, Roberta F. Colman and Robert W. Colman, Platelet Activation by 2‐(4‐bromo‐2,3‐dioxobutylthio)Adenosine 5′‐Diphosphate is Mediated by Its Binding to A Putative ADP Receptor, Aggregin, European Journal of Biochemistry, 236, 3, (862-870), (2004).
  Wiley Online Library
• Rajinder N. Puri, Ajay Kumar, Haiying Chen, Roberta F. Colman and Robert W. Colman, Inhibition of ADP-induced Platelet Responses by Covalent Modification of Aggregin, a Putative ADP Receptor, by 8-(4-Bromo-2,3-dioxobutylthio)ADP, Journal of Biological Chemistry, 270, 41, (24482), (1995).
  Crossref
• Ahmad Faili, Jacques Randon, B.Boris Vargaftig and Mohamed Hatmi, Reduction by arachidonic acid of prostaglandin i2-induced cyclic amp formation, Biochemical Pharmacology, 45, 9, (1815), (1993).
  Crossref
• Christian GACHET, Jean‐Pierre CAZENAVE, Philippe OHLMANN, Gerhard HILF, Thomas WIELAND and Karl H. JAKOBS, ADP receptor‐induced activation of guanine‐nucleotide‐binding proteins in human platelet membranes, European Journal of Biochemistry, 207, 1, (259-263), (2005).
  Wiley Online Library
• Rajinder N. Puri and Robert W. Colman, Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: Evidence for covalent modification of cysteine and lysine residues, Archives of Biochemistry and Biophysics, 286, 2, (419), (1991).
  Crossref
• G. GLEERUP and K. WINTHER, The effect of ageing on human platelet sensitivity to serotonin, European Journal of Clinical Investigation, 18, 5, (504-506), (2008).
  Wiley Online Library
• H. Stormorken, T. Lyberg, L. Hakvaag and B. Nakstad, Dissociation of the aggregating effect and the inhibitory effect upon cyclic adenosine monophosphate accumulation by adrenaline and adenosine diphosphate in human platelets, Thrombosis Research, 45, 4, (363), (1987).
  Crossref
• Ahn Chang-Ho, Akihiko Hamada, Duane D. Miller and Dennis R. Feller, Alpha-adrenoceptor-mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelets: In vitro, Biochemical Pharmacology, 35, 22, (4095), (1986).
  Crossref
• Roger Kerry and Michael C. Scrutton, Platelet Adrenoceptors, The Platelets, 10.1016/B978-0-12-455555-6.50037-0, (113-157), (1985).
  Crossref
• K. Winther, R. Klysner, A. Geisler and P.H. Andersen, Characterization of human platelet beta-adrenoceptors, Thrombosis Research, 40, 6, (757), (1985).
  Crossref
• Klaus Aktories and Karl H. Jakobs, Regulation of Platelet Cyclic AMP Formation, The Platelets, 10.1016/B978-0-12-455555-6.50043-6, (271-288), (1985).
  Crossref
• Roger Kerry and Michael C. Scrutton, Platelet β‐adrenoceptors, British Journal of Pharmacology, 79, 3, (681-691), (2012).
  Wiley Online Library
• Roger Kerry and Michael C Scrutton, Binding of {3H}-dihydroalprenolol and {3H}-acetobutolol to human blood platelets is not related to occupancy of β-adrenoceptors, Thrombosis Research, 29, 6, (583), (1983).
  Crossref
• Donald E. Macfarlane, David C. B. Mills and Prem C. Srivastava, Binding of 2-azidoadenosine [.beta.-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase, Biochemistry, 21, 3, (544), (1982).
  Crossref
• , POSTER COMMUNICATIONS, British Journal of Pharmacology, 77, S2, (497P-574P), (2012).
  Wiley Online Library
• Klaus P. Mellwig and Karl H. Jakobs, Inhibition of platelet adenylate cyclase by ADP, Thrombosis Research, 18, 1-2, (7), (1980).
  Crossref
• JACQUELINE A. GRANT and MICHAEL C. SCRUTTON, INTERACTION OF SELECTIVE α‐ADRENOCEPTOR AGONISTS AND ANTAGONISTS WITH HUMAN AND RABBIT BLOOD PLATELETS, British Journal of Pharmacology, 71, 1, (121-134), (2015).
  Wiley Online Library
• G. Moroff and C. H. Chang, Aggregation Response of Human Platelets Stored at 22 C as Platelet‐Rich Plasma, Transfusion, 19, 6, (704-718), (2003).
  Wiley Online Library
• J.E. Tateson, S. Moncada and J.R. Vane, Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets, Prostaglandins, 13, 3, (389), (1977).
  Crossref
• Huguette Michel, J. P. Caen, G. V. R. Born, R. Miller, Ghislaine Angles DAuriac and P. Meyer, Relation between the Inhibition of Aggregation and the Concentration of cAMP in Human and Rat Platelets, British Journal of Haematology, 33, 1, (27-38), (2008).
  Wiley Online Library
• Alfred J. Barber, Cyclic nucleotides and platelet aggregation effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes, Biochimica et Biophysica Acta (BBA) - General Subjects, 444, 2, (579), (1976).
  Crossref
• David C.B. Mills and Donald E. Macfarlane, Stimulation of human platelet adenylate cyclase by prostaglandin D2, Thrombosis Research, 5, 3, (401), (1974).
  Crossref
• Malcolm Johnson, Reginald Jessup and Peter W. Ramwell, The significance of protein disulfide and sulfhydryl groups in prostaglandin action, Prostaglandins, 5, 2, (125), (1974).
  Crossref
• Ulf Ljungqvist, Platelets in shock and trauma, Journal of Surgical Research, 15, 2, (132), (1973).
  Crossref
• Malcolm Johnson, Reginald Jessup and Peter Ramwell, Ultraviolet light modification of the prostaglandin receptor, Prostaglandins, 4, 4, (593), (1973).
  Crossref
• Don N. Harris, Nick S. Semenuk and Sidney M. Hess, Chapter 23. Agents Affecting Cyclic AMP Levels, , 10.1016/S0065-7743(08)61251-8, (224-233), (1973).
  Crossref